CS logo
small CS logo
Animi

Lages, Brazil
Cancer treatment center in Santa Catarina
R. Mal. Deodoro, 678 - Centro, Lages - SC, 88501-001

About Animi


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Nektar Therapeutics
1
Regeneron Pharmaceuticals
1
Total Rows: 2

Clinical Trials at Animi


During the past decade, Animi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011000000Started TrialsCompleted Trails20162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
2016-04-07
2023-10-19
Active, not recruiting
432
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
2018-12-18
2022-10-19
Terminated
623

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Animi" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNektar Therapeutics: 1Nektar Therapeutics: 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 1Bristol-Myers Squibb: 1

Clinical Trials Conditions at Animi


According to Clinical.Site data, the most researched conditions in "Animi" are "Advanced Cutaneous Squamous Cell Carcinoma" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Animi" in a lesser frequency.

Clinical Trials Intervention Types at Animi


Most popular intervention types in "Animi" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "bempegaldesleukin" (1 trials), "cabozantinib" (1 trials), "cemiplimab" (1 trials), "nivolumab" (1 trials) and "sunitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Animi


The vast majority of trials in "Animi" are 2 trials for "All" genders.

Clinical Trials Status at Animi


Currently, there are NaN active trials in "Animi". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Animi, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Animi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1